• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓移植受者中的感染

Infection in bone marrow transplant recipients.

作者信息

Meyers J D

出版信息

Am J Med. 1986 Jul 28;81(1A):27-38. doi: 10.1016/0002-9343(86)90511-5.

DOI:10.1016/0002-9343(86)90511-5
PMID:3090877
Abstract

Infection in marrow transplant recipients is determined primarily by the evolving immunologic milieu of each patient. Profound neutropenia and disruption of anatomic barriers are the most important risk factors for bacterial and fungal infections in the initial period after transplant. After this period, the occurrences of acute and then chronic graft-versus-host disease (GVHD) are the most important influences on the risk of infection. Major infections after the period of initial engraftment include viral infections (especially cytomegalovirus), fungal infections (due to Aspergillus and Candida), and rarely protozoal infections. GVHD appears to increase both the incidence and severity of cytomegalovirus infection. Bacterial infections also continue to occur, due predominantly to coagulase-negative Staphylococcus, as in the neutropenic period. Patients with chronic GVHD have continued abnormalities of host defenses, which may be further suppressed by treatment for GVHD. Major efforts have been directed toward preventing infection. In the neutropenic period, these include use of the protective environment, which has also been associated with a lower incidence of acute GVHD among patients who received transplants for aplastic anemia. The use of seronegative blood products is highly effective in preventing primary cytomegalovirus infection among seronegative patients. Among patients being treated for chronic GVHD, trimethoprim/sulfamethoxazole prophylaxis has been associated with a lower risk of infection.

摘要

骨髓移植受者的感染主要取决于每位患者不断变化的免疫环境。严重中性粒细胞减少和解剖屏障破坏是移植后初期细菌和真菌感染的最重要危险因素。在此期间之后,急性和慢性移植物抗宿主病(GVHD)的发生是对感染风险的最重要影响因素。初次植入期后的主要感染包括病毒感染(尤其是巨细胞病毒)、真菌感染(由曲霉菌和念珠菌引起),原生动物感染很少见。GVHD似乎会增加巨细胞病毒感染的发生率和严重程度。细菌感染也会继续发生,主要是凝固酶阴性葡萄球菌,与中性粒细胞减少期情况相同。慢性GVHD患者的宿主防御持续异常,可能会因GVHD治疗而进一步受到抑制。主要努力方向是预防感染。在中性粒细胞减少期,这些措施包括使用保护环境,这也与接受再生障碍性贫血移植的患者中急性GVHD发生率较低有关。使用血清阴性血液制品在预防血清阴性患者的原发性巨细胞病毒感染方面非常有效。在接受慢性GVHD治疗的患者中,甲氧苄啶/磺胺甲恶唑预防与较低的感染风险相关。

相似文献

1
Infection in bone marrow transplant recipients.骨髓移植受者中的感染
Am J Med. 1986 Jul 28;81(1A):27-38. doi: 10.1016/0002-9343(86)90511-5.
2
A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.相关供体外周血与骨髓移植的比较:迟发性慢性移植物抗宿主病和感染的重要性。
Biol Blood Marrow Transplant. 2003 Jan;9(1):52-9. doi: 10.1053/bbmt.2003.50000.
3
Marrow transplant experience for children with severe aplastic anemia.重度再生障碍性贫血患儿的骨髓移植经验
Am J Pediatr Hematol Oncol. 1994 Feb;16(1):43-9.
4
Antimicrobial prophylaxis in bone marrow transplantation.骨髓移植中的抗菌预防
Ann Intern Med. 1995 Aug 1;123(3):205-15. doi: 10.7326/0003-4819-123-3-199508010-00008.
5
Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease.异基因骨髓移植中的免疫调节:使用静脉注射免疫球蛋白抑制急性移植物抗宿主病。
Clin Exp Immunol. 1996 May;104 Suppl 1:43-8.
6
Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.接受来自 HLA 相同同胞的脐血或骨髓移植的儿童中的移植物抗宿主病。欧洲脐血库和国际骨髓移植登记处替代供体和干细胞来源工作委员会。
N Engl J Med. 2000 Jun 22;342(25):1846-54. doi: 10.1056/NEJM200006223422501.
7
Infectious complications of human bone marrow transplantation.人类骨髓移植的感染性并发症
Medicine (Baltimore). 1979 Jan;58(1):1-31. doi: 10.1097/00005792-197901000-00001.
8
Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome.骨髓移植后的非念珠菌真菌感染:危险因素与结局
Am J Med. 1994 Jun;96(6):497-503. doi: 10.1016/0002-9343(94)90088-4.
9
Pathology of bone marrow in transplant recipients.移植受者的骨髓病理学
Hematol Oncol Clin North Am. 1988 Dec;2(4):735-56.
10
Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.骨髓移植受者中,与巨细胞病毒血清学阳性供者、移植后巨细胞病毒感染、供者年龄小以及慢性移植物抗宿主病相关的移植物抗白血病活性。北欧骨髓移植组。
Bone Marrow Transplant. 1990 Jun;5(6):413-8.

引用本文的文献

1
Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein-Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant.同种异体造血干细胞移植儿童受者中抗病毒预防与巨细胞病毒和EB病毒血症之间的关联
Vaccines (Basel). 2021 Jun 7;9(6):610. doi: 10.3390/vaccines9060610.
2
Differing Virulence of Healthy Skin Commensals in Mouse Models of Infection.健康皮肤共生菌在感染小鼠模型中的毒力差异。
Front Cell Infect Microbiol. 2019 Jan 21;8:451. doi: 10.3389/fcimb.2018.00451. eCollection 2018.
3
Role of HRCT Chest in Post Stem Cell Transplant Recipients Suspected of Pulmonary Complications.
胸部高分辨率CT在怀疑有肺部并发症的干细胞移植受者中的作用
J Clin Diagn Res. 2016 Nov;10(11):TC18-TC23. doi: 10.7860/JCDR/2016/24387.8885. Epub 2016 Nov 1.
4
Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.在人类患者和小鼠接受异基因造血干细胞移植后,使用广谱抗生素会增加移植物抗宿主病(GVHD)相关死亡率。
Sci Transl Med. 2016 May 18;8(339):339ra71. doi: 10.1126/scitranslmed.aaf2311.
5
Current and potential treatments for ubiquitous but neglected herpesvirus infections.常见但被忽视的疱疹病毒感染的现有及潜在治疗方法。
Chem Rev. 2014 Nov 26;114(22):11382-412. doi: 10.1021/cr500255e. Epub 2014 Oct 2.
6
Hematopoietic stem cell transplantation.造血干细胞移植
Stem Cells Cloning. 2010 Aug 26;3:105-17. doi: 10.2147/SCCAA.S6815.
7
Maintenance of T cell function in the face of chronic antigen stimulation and repeated reactivation for a latent virus infection.在慢性抗原刺激和潜伏病毒感染的反复再激活的情况下维持 T 细胞功能。
J Immunol. 2012 Mar 1;188(5):2173-8. doi: 10.4049/jimmunol.1102719. Epub 2012 Jan 23.
8
Pneumonitis in human cytomegalovirus infection.人巨细胞病毒感染性肺炎。
Curr Infect Dis Rep. 2006 May;8(3):222-30. doi: 10.1007/s11908-006-0063-z.
9
In Vitro Anti-Cytomegalovirus Activity of Kampo (Japanese Herbal) Medicine.汉方(日本草药) medicine的体外抗巨细胞病毒活性。 (这里“medicine”原词可能有误,结合语境推测可能是“medicines”,完整准确的应是:汉方(日本草药)药物的体外抗巨细胞病毒活性 )
Evid Based Complement Alternat Med. 2004 Dec;1(3):285-289. doi: 10.1093/ecam/neh045. Epub 2004 Oct 27.
10
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients.骨髓移植受者巨细胞病毒监测的分子方法
J Clin Microbiol. 2002 Nov;40(11):4203-6. doi: 10.1128/JCM.40.11.4203-4206.2002.